Mutual Advisors, LLC Organon & Co. Transaction History

Mutual Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $12,632 - $15,521	-399 Reduced 5.53%	6,812 $230,000
Q1 2022 May 09, 2022	SELL	$30.45 - $39.36 $8,982 - $11,611	-295 Reduced 3.93%	7,211 $252,000
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $12,070 - $15,631	-421 Reduced 5.31%	7,506 $229,000
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $7,472 - $9,302	-261 Reduced 3.19%	7,927 $260,000
Q2 2021 Aug 12, 2021	BUY	$28.45 - $38.0 $232,948 - $311,144	8,188 New	8,188 $248,000

805

201M

1.53M

1.07M

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.94B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Mutual Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Advisors, LLC with notifications on news.